Back to BAILLIE GIFFORD & CO BAILLIE GIFFORD & CO

RPRXRPRX
Showing 8 of 18 quarters

Position history for BAILLIE GIFFORD & COBAILLIE GIFFORD & CO's holdings in ROYALTY PHARMA PLC- CL A

BAILLIE GIFFORD & CO holds 10M shares of RPRX (ROYALTY PHARMA PLC- CL A), worth $561.6M as of 2026-Q2. The position was decreased (-38.0% shares). RPRX represents 0.5% of BAILLIE GIFFORD & CO's portfolio.

Current Value

$561.6M

Current Shares

10M

Total Value Change

+$105.5M

Total Shares Change

-6.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
10M
-38.0%
$561.6M0.5%$55.85
0
2026-Q1
Decreased
16.2M
-5.0%
$775M0.8%$47.57
0
2025-Q4
Decreased
17M
-2.1%
$657.2M0.5%$38.12
0
2025-Q3
Decreased
17.4M
-3.6%
$612.9M0.5%$34.61
0
2025-Q2
Increased
18M
+34.5%
$649.3M0.5%$35.13
49
2025-Q1
Decreased
13.4M
-5.2%
$417.2M0.4%$30.15
0
2024-Q4
Decreased
14.1M
-12.3%
$360.6M0.3%$24.55
0
2024-Q3
Decreased
16.1M
-1.4%
$456.1M0.3%$27.00
0

Other major holders of RPRX: MORGAN STANLEY, ADAGE CAPITAL PARTNERS GP, L.L.C., Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used